↓ Skip to main content

Cochrane Database of Systematic Reviews

Angiogenesis inhibitors for the treatment of ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, September 2011
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
186 Mendeley
Title
Angiogenesis inhibitors for the treatment of ovarian cancer
Published in
Cochrane database of systematic reviews, September 2011
DOI 10.1002/14651858.cd007930.pub2
Pubmed ID
Authors

Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum, Jo Morrison

Abstract

Many women with ovarian cancer eventually develop resistance to conventional chemotherapy drugs, and so novel agents are being developed to target specific molecular pathways. One such class of drugs inhibits angiogenesis (the development of new blood vessels), which is essential for tumour growth. It is important to establish whether the addition of these new drugs to conventional chemotherapy regimens improves survival, and what the side-effects may be.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 2 1%
Spain 1 <1%
Italy 1 <1%
Unknown 182 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 13%
Researcher 22 12%
Student > Bachelor 20 11%
Student > Ph. D. Student 18 10%
Student > Doctoral Student 11 6%
Other 30 16%
Unknown 61 33%
Readers by discipline Count As %
Medicine and Dentistry 79 42%
Nursing and Health Professions 11 6%
Agricultural and Biological Sciences 10 5%
Biochemistry, Genetics and Molecular Biology 7 4%
Computer Science 4 2%
Other 14 8%
Unknown 61 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2011.
All research outputs
#20,043,000
of 25,498,750 outputs
Outputs from Cochrane database of systematic reviews
#12,099
of 13,141 outputs
Outputs of similar age
#111,866
of 136,583 outputs
Outputs of similar age from Cochrane database of systematic reviews
#103
of 110 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,141 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,583 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.